High-Pressure Transvenous Perfusion of the Upper Extremity in Human Muscular Dystrophy: A Safety Study with 0.9% Saline

Human Gene Therapy

Volumn 26, Issue 9, 2015, Pages 614-621

  Fan, Zheng ^a,b   Kocis, Keith ^a,b   Valley, Robert ^a   Howard, James F ^a,b   Chopra, Manisha ^a,b   Chen, Yasheng ^a   An, Hongyu ^a   Lin, Weili ^a   Muenzer, Joseph ^a,b   Powers, William ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; POTASSIUM; SODIUM CHLORIDE;

ADULT; ARM; ARTICLE; BODY WEIGHT; BREATHING RATE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DUCHENNE MUSCULAR DYSTROPHY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ELECTROPHYSIOLOGY; FEMALE; HEART FUNCTION; HUMAN; HUMAN EXPERIMENT; HYPERBARISM; INFUSION PUMP; INFUSION RATE; KIDNEY FUNCTION; LIMB GIRDLE MUSCULAR DYSTROPHY; LIMB PERFUSION; MALE; MUSCLE ACTION POTENTIAL; MUSCLE STRENGTH; MUSCULAR DYSTROPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN SATURATION; PATIENT SAFETY; PERFUSION; PERIPHERAL NERVE; POTASSIUM BLOOD LEVEL; SKELETAL MUSCLE; TISSUE OXYGENATION; GENE THERAPY; GENE TRANSFER; HISTORY; MIDDLE AGED; MUSCULAR DYSTROPHY, DUCHENNE; PRESSURE; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; FEMALE; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; HUMANS; MALE; MIDDLE AGED; MUSCULAR DYSTROPHY, DUCHENNE; PERFUSION; PRESSURE; SODIUM CHLORIDE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84932641203     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2015.023     Document Type: Article

References (31)

1. Mendell JR, Campbell K, Rodino-Klapac L, et al. Dystrophin immunity in Duchenne's muscular dystrophy. N Engl J Med 2010;363:1429-1437.
2. Mendell JR, Rodino-Klapac LR, Rosales-Quintero X, et al. Limb-girdle muscular dystrophy type 2d gene therapy restores alpha-sarcoglycan and associated proteins. Ann Neurol 2009;66:290-297.
3. Mendell JR, Sahenk Z, Malik V, et al. A phase 1/2a follistatin gene therapy trial for Becker muscular dystrophy. Mol Ther 2015;23:192-201.
4. Stedman H, Wilson JM, Finke R, et al. Phase I clinical trial utilizing gene therapy for limb girdle muscular dystrophy: Alpha-, beta-, gamma-, or delta-sarcoglycan gene delivered with intramuscular instillations of adeno-associated vectors. Hum Gene Ther 2000;11:777-790.
5. Hagstrom JE, Hegge J, Zhang G, et al. A facile nonviral method for delivering genes and sirnas to skeletal muscle of mammalian limbs. Mol Ther 2004;10:386-398.
6. Kamimura K, Zhang G, Liu D. Image-guided, intravascular hydrodynamic gene delivery to skeletal muscle in pigs. Mol Ther 2010;18:93-100.
7. Le Guiner C, Montus M, Servais L, et al. Forelimb treatment in a large cohort of dystrophic dogs supports delivery of a recombinant AAV for exon skipping in Duchenne patients. Mol Ther 2014;22:1923-1935.
8. Toromanoff A, Cherel Y, Guilbaud M, et al. Safety and efficacy of regional intravenous (R.I.) versus intramuscular (I.M.) delivery of rAAV1 and rAAV8 to nonhuman primate skeletal muscle. Mol Ther 2008;16:1291-1299.
9. Fan Z, Kocis K, Valley R, et al. Safety and feasibility of high-pressure transvenous limb perfusion with 0.9% saline in human muscular dystrophy. Mol Ther 2012;20:456-461.
10. Browse N, Burnand K, Irvine A, Wilson N. Disease of the Veins. (Arnold, London), 1999.
11. Glovicki P. Venous embryology and anatomy. In: The Vein. J Bergan, N Bunke-Paquette, eds. (Oxford University Press, New York, NY). 2014; pp. 17-26.
12. Konstantakos EK, Dalstrom DJ, Nelles ME, et al. Diagnosis and management of extremity compartment syndromes: An orthopaedic perspective. Am Surg 2007;73:1199-1209.
13. Labropoulos N, Tiongson J, Pryor L, et al. Definition of venous reflux in lower-extremity veins. J Vasc Surg 2003;38:793-798.
14. Yozbatiran N, Der-Yeghiaian L, Cramer SC. A standardized approach to performing the action research arm test. Neurorehabil Neural Repair 2008;22:78-90.
15. Van Den Brand JG, Nelson T, Verleisdonk EJ, Van Der Werken C. The diagnostic value of intracompartmental pressure measurement, magnetic resonance imaging, and near-infrared spectroscopy in chronic exertional compartment syndrome: A prospective study in 50 patients. Am J Sports Med 2005;33:699-704.
16. Marsch SC, Sluga M, Studer W, et al. 0.5% versus 1.0% 2-chloroprocaine for intravenous regional anesthesia: A prospective, randomized, double-blind trial. Anesth Analg 2004;98:1789-1793.
17. Comunale ME. A laboratory evaluation of the level 1 rapid infuser (h1025) and the Belmont Instrument Fluid Management System (FMS 2000) for rapid transfusion. Anesth Analg 2003;97:1064-1069.
18. Fan Z, Powers W, Kornegay J, Xiao X. Pressurized transvenous-retrograde extremity perfusion. In: Gene and Cell Therapy: Therapeutic Mechanisms and Strategies. N Templeton, ed. (CRC Press, New York, NY). 2015; pp. 439-449.
19. Yushkevich PA, Piven J, Hazlett HC, et al. Userguided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability. Neuroimage 2006;31:1116-1128.
20. Yushkevich PA, Gerig G, Soldea O, Gao Y. (2014). www.itksnap.org (last accessed June 22, 2015).
21. Florence JM, Fox PT, Planer GJ, Brooke MH. Activity, creatine kinase, and myoglobin in Duchenne muscular dystrophy: A clue to etiology? Neurology 1985;35:758-761.
22. Jackson MJ, Round JM, Newham DJ, Edwards RH. An examination of some factors influencing creatine kinase in the blood of patients with muscular dystrophy. Muscle Nerve 1987;10:15-21.
23. Escolar DM, Henricson EK, Mayhew J, et al. Clinical evaluator reliability for quantitative and manual muscle testing measures of strength in children. Muscle Nerve 2001;24:787-793.
24. Rodino-Klapac LR, Montgomery CL, Mendell JR, Chicoine LG. AAV-mediated gene therapy to the isolated limb in rhesus macaques. Methods Mol Biol 2011;709:287-298.
25. Collins JM, Despa F, Lee RC. Structural and functional recovery of electropermeabilized skeletal muscle in-vivo after treatment with surfactant poloxamer 188. Biochim Biophys Acta 2007;1768: 1238-1246.
26. Schmelzer JD, Zochodne DW, Low PA. Ischemic and reperfusion injury of rat peripheral nerve. Proc Natl Acad Sci USA 1989;86:1639-1642.
27. Hegge JO, Wooddell CI, Zhang G, et al. Evaluation of hydrodynamic limb vein injections in nonhuman primates. Hum Gene Ther 2010;21: 829-842.
28. Qiao C, Li J, Zheng H, et al. Hydrodynamic limb vein injection of adeno-associated virus serotype 8 vector carrying canine myostatin propeptide gene into normal dogs enhances muscle growth. Hum Gene Ther 2009;20:1-10.
29. Barry L, Balliana S, Galeppi A. Intravenous regional anesthesia (Bier block). Techn Reg Anesth Pain Manag 2006;10:123-131.
30. Vigen KK, Hegge JO, Zhang G, et al. Magnetic resonance imaging-monitored plasmid DNA delivery in primate limb muscle. Hum Gene Ther 2007;18:257-268.
31. Kornegay JN, Li J, Bogan JR, et al. Widespread muscle expression of an AAV9 human mini-dystrophin vector after intravenous injection in neonatal dystrophin-deficient dogs. Mol Ther 2010;18: 1501-1508.